On March 8, Northeastern clinical lab test provider Bio-Reference Labs
- Total revenue grew 25%, attributed to a 15% increase in year-over-year patient count, as well as higher revenue per patient. Bio-Reference appears to be picking up business from the ramifications of UnitedHealth Group's
(NYSE:UNH) decision to drop rival Quest Diagnostics(NYSE:DGX) in favor of LabCorp(NYSE:LH) . While the contract shifts, other providers are picking up the slack. - Margins improved as more profitable esoteric testing grew from 36% of revenue to 43%.
- Diluted earnings grew 56% as margin improvements and strong sales trends boosted bottom-line results.
- Bio-Reference carries a four-star rating in the Motley Fool CAPS intelligence database, while larger rivals Quest and LabCorp carry the coveted five-star rating. Feel free to head to CAPS and tell us what you think about these companies and more.
(Figures in thousands, except per-share data)
Income Statement Highlights*
Avg. Est. |
Q1 2007 |
Q1 2006 |
Change |
|
---|---|---|---|---|
Sales |
$52,160 |
$53,722 |
$42,918 |
25.2% |
Net Profit |
-- |
$1,966 |
$1,153 |
70.5% |
EPS |
$0.12 |
$0.14 |
$0.09 |
55.6% |
Diluted Shares |
-- |
13,839 |
13,407 |
3.2% |
Get back to basics with a look at the income statement.
Margin Checkup
Q1 2007 |
Q1 2006 |
Change* |
|
---|---|---|---|
Gross Margin |
48.76% |
47.38% |
1.38 |
Operating Margin |
6.68% |
4.65% |
2.03 |
Net Margin |
3.66% |
2.69% |
0.97 |
Margins are the earnings engine. See how they work.
Balance Sheet Highlights
Assets |
Q1 2007 |
Q1 2006 |
Change |
---|---|---|---|
Cash + ST Invest. |
$9,601 |
$5,343 |
79.7% |
Accounts Rec. |
$72,373 |
$56,407 |
28.3% |
Liabilities |
Q1 2007 |
Q1 2006 |
Change |
---|---|---|---|
Accounts Payable |
$19,083 |
$13,454 |
41.8% |
Long-Term Debt |
$10,655 |
$0 |
n/a |
Learn the ways of the balance sheet.
Cash Flow Highlights
Fools will have to wait until Bio-Reference files its quarterly 10-Q with the Securities and Exchange Commission for juicy cash flow details. Find out why Fools always follow the money.
Related Foolishness:
UnitedHealth and LabCorp are both Stock Advisor picks, and while UnitedHealth is also an Inside Value recommendation. Follow the preceding links to try either newsletter free for 30 days.
Fool by Numbers is designed to give you the raw earnings information in a timely fashion, putting all the numbers you need in one easy-to-read place. But at The Motley Fool, we believe numbers tell only part of the story, so check Fool.com for more of our in-depth discussion of what the numbers mean.
Fool contributor Ryan Fuhrmann has no financial interest in any company mentioned. Feel free to email him with feedback or to discuss any companies mentioned further. The Fool has an ironclad disclosure policy.